PEPTAS made-to-order material
LL-37 5mg
| Catalog ID | PEP-LL37-005 |
|---|---|
| Molecular class | Linear peptides |
| Availability | Made to order |
LL-37 5mg research material identified as a 37-residue peptide sequence and limited to qualified laboratory use.
Quoted per order; schedule confirmed in the quotation.
Prices are quoted in writing. Quantity, pack format, documentation and destination all affect the price, and each complete request is reviewed before a quotation is issued.
Larger and recurring quantities are quoted through Volume and recurring supply.
This catalog entry records chemical identity information for a laboratory research material. It is not a quotation or a commitment to supply.
Documentation for this item. Analytical documentation available for the material and batch is confirmed in the quotation. What can be requested.
Identity and procurement context
Product information
PEPTAS catalog record
About LL-37 5mg
LL-37 designates a 37-residue peptide research material. This PEPTAS 5mg listing is strictly for lawful professional research. The name does not establish sequence or analytical details. The listing makes no claims of biological effect, and it must not be interpreted as permission for any human, veterinary, household, or environmental application.
- Catalog item
- LL-37 5mg
- Material class
- Thirty-seven-residue peptide research material
- Permitted context
- Qualified laboratory research only
LL-37 5mg specifications
- CAS registry number
- 154947-66-7
- Molecular formula
- C205H340N60O53
- Molecular weight
- 4493.3 g/mol (average)
- Physical form
- Lyophilized powder
- Purity stated on packaging
- ≥ 98.8% (HPLC)
- Storage
- Stored and shipped as stated on the packaging and in the order documentation. See Quality control.
Free-acid composition; the counterion is confirmed for the accepted order.
These identifiers describe the catalog material. The molecular weight shown is the average mass calculated from the molecular formula above. The purity figure above is the specification printed on the packaging, not a result for any particular lot — batch-specific analytical documentation is confirmed for the actual item or accepted order. See Quality control.
Planning work with this material
Distinguish full-length LL-37 from fragments and analogs by confirming sequence, termini, and counterion before ordering. The purchasing laboratory must independently define and validate controls for preparation conditions and containers.
Record package condition and lot details at arrival. Quarantine any item that conflicts with the accepted order documentation.
Documentation and order review
Availability, product identity, listed quantity, price, packaging, transport terms, storage information, and any supporting analytical documents are confirmed for the actual item or accepted order. Request the information your project requires before purchasing; a general catalog page cannot replace an order-specific specification or certificate.
- Confirm purchaser eligibility, destination rules, permits, and institutional approvals.
- Define identity and analytical acceptance criteria before the material is received.
- Inspect the package, identifier, quantity, lot information, and documents on arrival.
- Maintain controlled access, storage, preparation, traceability, and disposal records.
Research-use conditions
Not for human or veterinary use. This material is not a medicine, food, dietary supplement, cosmetic, diagnostic product, or household product. It must not be administered, consumed, compounded for administration, used for self-experimentation, or represented as suitable for the diagnosis, treatment, mitigation, cure, or prevention of any condition.
Purchasers are responsible for lawful acquisition and use, competent risk assessment, suitable facilities and personnel, appropriate personal protective equipment, validated procedures, security, incident response, and waste disposal. Website information is not medical, veterinary, legal, regulatory, or scientific-protocol advice.